INTUITIVE SURGICAL INC (ISRG)
US46120E6023 - Common Stock
ISRG gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 192 industry peers in the Health Care Equipment & Supplies industry. ISRG has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ISRG is growing strongly while it is still valued neutral. This is a good combination! These ratings could make ISRG a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
ISRG had positive earnings in the past year.
In the past year ISRG had a positive cash flow from operations.
ISRG had positive earnings in each of the past 5 years.
Each year in the past 5 years ISRG had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 12.56%, ISRG belongs to the top of the industry, outperforming 95.85% of the companies in the same industry.
ISRG's Return On Equity of 14.24% is amongst the best of the industry. ISRG outperforms 89.64% of its industry peers.
Looking at the Return On Invested Capital, with a value of 11.37%, ISRG belongs to the top of the industry, outperforming 93.26% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ISRG is above the industry average of 8.42%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.56% | ||
| ROE | 14.24% | ||
| ROIC | 11.37% |
ROA(3y)11.47%
ROA(5y)11.62%
ROE(3y)13.27%
ROE(5y)13.48%
ROIC(3y)12.21%
ROIC(5y)11.96%
1.3 Margins
ISRG has a Profit Margin of 27.16%. This is amongst the best in the industry. ISRG outperforms 97.41% of its industry peers.
In the last couple of years the Profit Margin of ISRG has declined.
ISRG's Operating Margin of 25.44% is amongst the best of the industry. ISRG outperforms 95.85% of its industry peers.
In the last couple of years the Operating Margin of ISRG has declined.
Looking at the Gross Margin, with a value of 66.43%, ISRG is in the better half of the industry, outperforming 71.50% of the companies in the same industry.
In the last couple of years the Gross Margin of ISRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.44% | ||
| PM (TTM) | 27.16% | ||
| GM | 66.43% |
OM growth 3Y0.73%
OM growth 5Y-5.65%
PM growth 3Y1.22%
PM growth 5Y-3.58%
GM growth 3Y0.37%
GM growth 5Y-1.03%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ISRG is still creating some value.
ISRG has more shares outstanding than it did 1 year ago.
ISRG has more shares outstanding than it did 5 years ago.
ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
ISRG has an Altman-Z score of 47.28. This indicates that ISRG is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ISRG (47.28) is better than 98.96% of its industry peers.
There is no outstanding debt for ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 47.28 |
ROIC/WACC1.18
WACC9.6%
2.3 Liquidity
ISRG has a Current Ratio of 5.55. This indicates that ISRG is financially healthy and has no problem in meeting its short term obligations.
ISRG has a better Current ratio (5.55) than 72.02% of its industry peers.
A Quick Ratio of 4.61 indicates that ISRG has no problem at all paying its short term obligations.
ISRG has a Quick ratio of 4.61. This is in the better half of the industry: ISRG outperforms 71.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.55 | ||
| Quick Ratio | 4.61 |
3. Growth
3.1 Past
ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.84%, which is quite impressive.
ISRG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.97% yearly.
ISRG shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.81%.
ISRG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.85% yearly.
EPS 1Y (TTM)24.84%
EPS 3Y19.06%
EPS 5Y8.97%
EPS growth Q2Q21.95%
Revenue 1Y (TTM)13.81%
Revenue growth 3Y17.8%
Revenue growth 5Y13.85%
Revenue growth Q2Q11.46%
3.2 Future
ISRG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.55% yearly.
ISRG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.39% yearly.
EPS Next Y11.63%
EPS Next 2Y14.35%
EPS Next 3Y15.53%
EPS Next 5Y15.55%
Revenue Next Year13.01%
Revenue Next 2Y14.19%
Revenue Next 3Y14.68%
Revenue Next 5Y13.39%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 66.69, which means the current valuation is very expensive for ISRG.
Based on the Price/Earnings ratio, ISRG is valued a bit cheaper than 69.43% of the companies in the same industry.
ISRG is valuated expensively when we compare the Price/Earnings ratio to 28.60, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 53.42, ISRG can be considered very expensive at the moment.
ISRG's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ISRG is cheaper than 68.39% of the companies in the same industry.
ISRG's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.15.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 66.69 | ||
| Fwd PE | 53.42 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ISRG is valued a bit cheaper than 69.43% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ISRG indicates a somewhat cheap valuation: ISRG is cheaper than 67.36% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 237.44 | ||
| EV/EBITDA | 57.59 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ISRG has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ISRG's earnings are expected to grow with 15.53% in the coming years.
PEG (NY)5.73
PEG (5Y)7.44
EPS Next 2Y14.35%
EPS Next 3Y15.53%
5. Dividend
5.1 Amount
ISRG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
INTUITIVE SURGICAL INC
NASDAQ:ISRG (5/17/2024, 7:06:52 PM)
After market: 400.194 +1.37 (+0.34%)398.82
+2.39 (+0.6%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap141.47B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 66.69 | ||
| Fwd PE | 53.42 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)5.73
PEG (5Y)7.44
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.56% | ||
| ROE | 14.24% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 25.44% | ||
| PM (TTM) | 27.16% | ||
| GM | 66.43% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 5.55 | ||
| Quick Ratio | 4.61 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)24.84%
EPS 3Y19.06%
EPS 5Y
EPS growth Q2Q
EPS Next Y11.63%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)13.81%
Revenue growth 3Y17.8%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y